Navigation Links
Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for Asthma or Allergies without Trying First-Line Medications End Up Staying on the Medication
Date:4/27/2011

ST. PAUL, Minn., April 27, 2011 /PRNewswire/ -- Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair®) instead of typical first-line therapy have low rates of persistence on montelukast and may ultimately discontinue therapy altogether, according to a new study presented at the Academy of Managed Care Pharmacy's 23rd Annual Meeting in Minneapolis, Minn. The study will be presented by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management.

Montelukast is FDA-approved for treatment of asthma and allergic rhinitis. It works by inhibiting leukotrienes, the chemicals that cause inflammation. Montelukast is considered a second line of defense against asthma or allergic rhinitis. Typical first-line therapies are inhaled corticosteroids for asthma and nasal steroids for allergic rhinitis. The inhaled steroids act locally by concentrating their effects directly within the breathing passages, with very few side effects outside of the lungs or sinuses.

For the study, researchers identified 907 individuals with asthma who filled a claim for newly initiated montelukast therapy in the fourth quarter of 2009. An additional 373 people with allergic rhinitis or allergies who initiated montelukast therapy during the same time period were also identified. Patients were followed for 120 days after their first claim was filled to assess whether they continued to take montelukast after 30, 60, 90 and 120 days.

At 120 days after initiating montelukast therapy, 30.9 percent of asthma patients still had a supply of this medication. A similar poor persistence on montelukast treatment at 120 days was noted in patients with allergic rhinitis. In addition, at 120 days after montelukast was initiated, the vast majority of asthma and allergic rhinitis patients were lacking any therapy (62.6 and 64.9 percent, respectively).

"Continued drug treatment is essential for managing asthma," said
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study
2. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... FRANCISCO, Calif. , March 6, 2015   ... announced new data demonstrating that diagnostic tests that use ... nodules can dramatically reduce the specificity of test results, ... benign nodules are erroneously diagnosed as cancerous. In addition, ... miss half of the malignancies leading to "false negatives." ...
(Date:3/6/2015)... March 6, 2015 Lucerne Biosciences, LLC ... publication of U.S. Patent Application No. 14/464,249 entitled ... Application features claimed methods of "informing a user" ... treat Binge Eating Disorder (,BED,)," including by reference ... or an advertisement," as well as by presentation ...
(Date:3/5/2015)... DETROIT , March 5, 2015   ... percent and met all seven optional leading indicators ... Benefit Management. "We are very proud ... said Rene Acker , Chief Operating Officer ... employees, dedication and commitment to transparency, flexibility and ...
Breaking Medicine Technology:Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2MeridianRx Earns Highest URAC Accreditation Status 2
... LAUDERDALE, Fla., Dec. 13, 2010 The creators of the innovative ... donating toys and a much needed medication management system to ... Hospital at Broward General, in Fort Lauderdale, Florida. ... Inc. will be onsite Wednesday, December 15, from 1-3 pm ...
... Dec. 13, 2010 HealthLeaders-InterStudy, a leading provider ... innovative care management solution in the Phoenix market ... the recent West Health Plan Analysis , ... to create virtual medical homes that allow non-traditional ...
Cached Medicine Technology:Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Children's Hospital of Broward General 2Use of Non-Traditional Providers in the Phoenix Market Will Improve Diabetes Prescription Drug Adherence 2
(Date:3/6/2015)... Texas (PRWEB) March 06, 2015 First ... 7am today. The new facility is located at 13351 W. ... “Our experienced clinical team is ready 24-7 to provide the ... Dr. Grossman, Facility Medical Director of First Choice Emergency Room ... ribbon cutting with the South Metro Denver Chamber of Commerce ...
(Date:3/6/2015)... Washington, DC (PRWEB) March 06, 2015 ... the nation’s only comprehensive source for key trends and ... specialty spend, medical injectables. Executives from Magellan Rx Management ... Pharmacy Trend Report: Discover Your Hidden Specialty Drug Spend,” ... Atlantic Information Services, Inc. , Specialty drug spend makes ...
(Date:3/6/2015)... 06, 2015 In a new study conducted ... patients reported that shoulder pain was their first mesothelioma symptom. ... website. Click here to read it now. , ... medical records of 49 mesothelioma patients between 2006 ... it was shoulder pain that first prompted them to see ...
(Date:3/6/2015)... You Wealth Revolution ( http://www.youwealthrevolution.com/info ... ‘energy’ experiment to determine if quick remote meditations ... quick ‘5 -7 minute’ remote energy and consciousness ... their life improving - often times very quickly. ... According to research, respondents saw the following common ...
(Date:3/6/2015)... Springs, FL (PRWEB) March 06, 2015 The ... present March 2015 air dates for Spokane, Washington and vicinity. ... colorful places to shop and dine, and many outdoor activities. ... industry supporting the local economy. Six major hospitals call the ... to the Canadian border. The medically-focused cable TV program will ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2
... consumers can ask their pharmacists OMAHA, Neb., Feb. 10 ... smart with their money. When it comes to ... prescriptions written by physicians to less expensive substitutes. But ... anything but, according to Dr. Ivan Abdouch, president of ...
... B. Braun Medical Inc. (B. Braun), a global ... well as a pioneer in passive safety devices ... it has been awarded a three-year contract by ... continuous renal replacement therapy (CRRT) dialysis products. (Logo: ...
... NumbersVIRGINIA BEACH, Va., Feb. 10 According to ... the lives of 406 people and distribute 300,348 ... a 13% increase from 2007 to 2008 in ... physicians. LifeNet Health provided 300,348 allograft bio-implants ...
... Day often includes expensive dinners and fattening candy -- ... a recent American Heart Association survey suggest couples would ... walks on the beach, in a park and at ... with their significant other while on a walk and ...
... Feb. 10 SurgiQuest, Inc. AirSeal Dynamic Pressure ... evacuation. The AirSeal DPS(TM) continuously re-circulates and filters ... surgical procedures.Surgeons routinely have to interrupt laparoscopic surgical ... smoke and plume within the operative environment. This ...
... to Drive Performance Improvements World WideLONDON, Ontario, Feb. ... today that GlaxoSmithKline PLC (GSK) has signed a ... business intelligence solution for their world wide manufacturing ... GSK experienced the ease of use that empowers ...
Cached Medicine News:Health News:Patients Urged to be Aware of Prescription Switching 2Health News:B. Braun Wins Premier Contract for Full Line of Dialysis Products 2Health News:B. Braun Wins Premier Contract for Full Line of Dialysis Products 3Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 2Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 3Health News:American Heart Association Survey: Romance and Walking a Perfect Match 2Health News:SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM) 2Health News:Activplant Corporation Announces Global Agreement with GlaxoSmithKline 2
Shielding's Fast Wrap Apron offers both comfort and ease of wearing. Adjustable back shoulder strap keeps apron snug. No ties or buckles....
Shielding's Economy Coat Apron offers the same features as our Standard Coat Apron with an open back allowing for freedom of movement, maximum flexibility and increased comfort....
Lap pad used to protect pelvic regions...
The front of this apron is tapered for maximum adjustability as needed. We can include a specially designed half-apron to be worn under the full apron for double protection in the abdomen/pelvic cav...
Medicine Products: